GO
Loading...

Amgen Inc

More

  • Final Glance: Biotechnology companies Thursday, 26 Mar 2015 | 6:07 PM ET

    Amgen Inc. fell$. 07 or percent, to $160.55. Biogen Idec fell $2.70 or. 6 percent, to $428.93. Celgene Corp. rose$. 67 or. 6 percent, to $117.66.

  • Midday Glance: Biotechnology companies Thursday, 26 Mar 2015 | 2:20 PM ET

    Amgen Inc. rose$. 17 or. 1 percent, to $160.79. Biogen Idec fell $3.13 or. 7 percent, to $428.51. Celgene Corp. rose$. 85 or. 7 percent, to $117.84.

  • Early Glance: Biotechnology companies Thursday, 26 Mar 2015 | 10:34 AM ET

    Amgen Inc. rose$. 38 or. 2 percent, to $161.00. Biogen Idec fell $6.27 or 1.5 percent, to $425.36. Celgene Corp. rose $1.13 or 1.0 percent, to $118.12.

  • Final Glance: Biotechnology companies Wednesday, 25 Mar 2015 | 6:03 PM ET

    Amgen Inc. fell $5.39 or 3.2 percent, to $160.62. Biogen Idec fell $21.08 or 4.7 percent, to $431.63. Celgene Corp. fell $5.16 or 4.2 percent, to $116.99.

  • Midday Glance: Biotechnology companies Wednesday, 25 Mar 2015 | 1:43 PM ET

    Amgen Inc. fell $3.89 or 2.3 percent, to $162.13. Biogen Idec fell $19.26 or 4.3 percent, to $433.45. Celgene Corp. fell $3.99 or 3.3 percent, to $118.16.

  • Early Glance: Biotechnology companies Wednesday, 25 Mar 2015 | 11:55 AM ET

    Amgen Inc. fell $2.19 or 1.3 percent, to $163.83. Biogen Idec fell $11.90 or 2.6 percent, to $440.81. Celgene Corp. fell $1.58 or 1.3 percent, to $120.57.

  • Final Glance: Biotechnology companies Tuesday, 24 Mar 2015 | 8:17 PM ET

    Amgen Inc. fell$. 53 or. 3 percent, to $166.01. Biogen Idec fell $11.02 or 2.4 percent, to $452.71. Celgene Corp. fell$. 79 or. 6 percent, to $122.15.

  • Midday Glance: Biotechnology companies Tuesday, 24 Mar 2015 | 1:19 PM ET

    Amgen Inc. fell$. 06 or percent, to $166.48. Biogen Idec fell $4.40 or. 9 percent, to $459.34. Gilead Sciences Inc. rose $1.52 or 1.5 percent, to $101.78.

  • Final Glance: Biotechnology companies Monday, 23 Mar 2015 | 6:03 PM ET

    Amgen Inc. fell $3.56 or 2.1 percent, to $166.54. Biogen Idec fell $12.25 or 2.6 percent, to $463.73. Celgene Corp. fell $5.56 or 4.3 percent, to $122.94.

  • Midday Glance: Biotechnology companies Monday, 23 Mar 2015 | 1:32 PM ET

    Amgen Inc. fell $3.35 or 2.0 percent, to $166.75. Biogen Idec fell $11.26 or 2.4 percent, to $464.72. Celgene Corp. fell $4.92 or 3.8 percent, to $123.58.

  • Early Glance: Biotechnology companies Monday, 23 Mar 2015 | 10:12 AM ET

    Amgen Inc. fell $3.94 or 2.3 percent, to $166.16. Biogen Idec fell $7.09 or 1.5 percent, to $468.89. Celgene Corp. fell $4.67 or 3.6 percent, to $123.83.

  • *Up from three potential $1 billion- plus drugs in 2014. LONDON, March 23- Bristol-Myers Squibb, Sanofi and Novartis have the three top new drugs set to reach the market in 2015, among 11 products each with $1 billion- plus sales potential, according to a Thomson Reuters analysis. In total, 11 of the many new drugs set for launch in 2015 are expected to generate $1 billion-...

  • *Up from three potential $1 billion- plus drugs in 2014. LONDON, March 23- Bristol-Myers Squibb, Sanofi and Novartis have the three top new drugs set to reach the market in 2015, among 11 products each with $1 billion- plus sales potential, according to a Thomson Reuters analysis. In total, 11 of the many new drugs set for launch in 2015 are expected to generate $1 billion-...

  • Final Glance: Biotechnology companies Friday, 20 Mar 2015 | 8:00 PM ET

    Amgen Inc. rose$. 99 or. 6 percent, to $170.10. Biogen Idec rose $42.33 or 9.8 percent, to $475.98. Celgene Corp. rose $3.17 or 2.5 percent, to $128.50.

  • Midday Glance: Biotechnology companies Friday, 20 Mar 2015 | 1:25 PM ET

    Amgen Inc. rose$. 39 or. 2 percent, to $169.50. Biogen Idec rose $38.60 or 8.9 percent, to $472.25. Celgene Corp. rose $1.36 or 1.1 percent, to $126.69.

  • Early Glance: Biotechnology companies Friday, 20 Mar 2015 | 10:19 AM ET

    Amgen Inc. rose $1.93 or 1.1 percent, to $171.04. Biogen Idec rose $29.86 or 6.9 percent, to $463.51. Celgene Corp. rose $1.29 or 1.0 percent, to $126.62.

  • Cramer: Snap up this incredible opportunity Thursday, 19 Mar 2015 | 6:22 PM ET
    Lab technician handling test tubes

    Jim Cramer can't believe how Esperion Therapeutics stock has shot through the roof! Can it keep going?

  • NEW YORK, March 19- A U.S. judge on Thursday denied Amgen Inc's bid to block the sale of Novartis AG's recently approved "biosimilar" form of Neupogen, Amgen's blockbuster drug used to prevent infections in cancer patients. The judge denied Amgen's request for a preliminary injunction to prevent Novartis' Sandoz unit from launching its copycat drug.

  • Midday Glance: Biotechnology companies Thursday, 19 Mar 2015 | 2:00 PM ET

    Amgen Inc. rose $1.24 or. 7 percent, to $167.78. Biogen Idec rose $7.84 or 1.8 percent, to $435.77. Celgene Corp. rose $2.16 or 1.8 percent, to $124.84.

  • Early Glance: Biotechnology companies Thursday, 19 Mar 2015 | 10:22 AM ET

    Amgen Inc. rose $1.31 or. 8 percent, to $167.85. Biogen Idec rose $9.78 or 2.3 percent, to $437.71. Celgene Corp. rose $2.07 or 1.7 percent, to $124.75.